Invesco India Smallcap Fund - Direct (IDCW) - Mutual Fund Analysis | Complete Fund Review with Performance, Portfolio, and Risk Analysis
Comprehensive analysis of Invesco India Smallcap Fund - Direct (IDCW) (38350) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
Invesco India Smallcap Fund - Direct (IDCW)
Invesco Asset Management (India) Pvt Ltd
To generate capital appreciation by investing predominantly in stocks of Smallcap companies. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
Fund Health Radar
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Performance
Moderate Returns
Risk
High Risk
Expenses
Low Expense Ratio
Portfolio Mix
Equity Focused
Management
Seasoned Team
Quality Score
Average Quality
Invesco India Smallcap Fund - Direct (IDCW) - NAV History (1Y)
Showing 1Y NAV history
Performance across different time periods
Neutral Entry Point
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Neutral Entry Point
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Key Factors Analysis
Long-term Track Record
Historical performance consistency
Equity Exposure
Market exposure level
Alpha Generation
Outperformance vs benchmark
Cost Efficiency
Fund management costs
1-Year Returns
Recent performance momentum
Management Stability
Fund manager experience
Fund Size
Assets under management
Risk Assessment
Risk-adjusted returns
Investment Timing Insights
3Y Performance Comparison
This fund has outperformed its benchmark by 8.50% over the 3Y period.
See how your money can grow and compare with popular investment options
Your Investment
Compare With Popular Options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
Risk Metrics (3 Years)
Risk Level
| Company | Sector | % Assets |
|---|---|---|
| Sai Life Sciences Ltd | Pharmaceuticals | 4.13% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 4.06% |
| Multi Commodity Exchange of India Ltd | Financial Services | 3.50% |
| Swiggy Ltd | E-Commerce/App based Aggregator | 3.24% |
| Interglobe Aviation Ltd | Air Transport Service | 3.03% |
| JK Lakshmi Cement Ltd | Cement | 2.99% |
| BSE Ltd | Financial Services | 2.93% |
| Karur Vysya Bank Ltd | Banks | 2.80% |
| Global Health Ltd | Healthcare | 2.73% |
| Cholamandalam Financial Holdings Ltd | Finance | 2.70% |
Sector Breakdown
Compare against Small Cap Fund category average
Performance Summary
This comparison shows how the fund performs relative to the Small Cap Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Small Cap Fund category
Invesco India Smallcap Fund - Direct (IDCW) vs Category Average
Similar Funds Comparison
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Kotak Small Cap Fund - Direct (G) | ₹305.75 | 20.35% | -5.69% | 17.20% |
| Sundaram Small Cap Fund - Direct (G) | ₹291.56 | 24.41% | -2.76% | 21.09% |
| Quant Small Cap Fund - Direct (G) | ₹282.01 | 18.46% | -9.78% | 25.25% |
| Sundaram Small Cap Fund (G) | ₹262.68 | 23.74% | -3.80% | 19.76% |
| Kotak Small Cap Fund (G) | ₹259.86 | 19.68% | -6.75% | 15.80% |
| Quant Small Cap Fund - (G) | ₹259.02 | 17.91% | -10.62% | 23.94% |
| Quant Small Cap Fund - Direct (IDCW) | ₹220.44 | 18.45% | -9.78% | 25.26% |
| DSP Small Cap Fund - Direct (G) | ₹211.66 | 26.23% | -1.41% | 21.46% |
| Quant Small Cap Fund - (IDCW) | ₹205.98 | 17.91% | -10.62% | 23.97% |
| SBI Small Cap Fund - Direct (G) | ₹196.95 | 18.67% | -5.52% | 16.12% |
Category Average Returns
Taher Badshah
A seasoned investment professional with over 7 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.